GlassScriptPhysician profile
Manish Wani
NPI 1457348963
$100,427.58
in general payments reported to CMS, 2019-2025
21 companies · $1,155 in 2025
The $1,155 reported for 2025 was more than what 82% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44K · 2020: $16K · 2021: $9,627 · 2022: $25K · 2023: $2,621 · 2024: $2,935 · 2025: $1,155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,892 · Consulting Fee: $1,500 · Travel and Lodging: $1,318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,891.81 |
| Consulting Fee | $1,500.00 |
| Travel and Lodging | $1,318.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $86,180.57 | 2019-2025 | N/A, Clarifix Cryotherapy Device, Xpress Ent Dilation System |
| Checkpoint Surgical, INC | $5,288.00 | 2020 | |
| Inspire Medical Systems, INC. | $5,157.30 | 2021-2025 | Inspire |
| Intersect Ent, INC. | $842.94 | 2019-2021 | |
| Optinose US, INC. | $611.75 | 2019-2025 | |
| Aerin Medical INC. | $543.81 | 2019-2024 | |
| Neurent Medical Limited | $376.82 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark System, Neuromark Device |
| Medtronic, INC. | $303.73 | 2022-2025 | Propel, Sinuva, Nuvent |
| Glaxosmithkline, LLC. | $203.80 | 2022-2025 | Nucala |
| Integra Lifesciences Corporation | $165.84 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Hologic Sales and Service, LLC | $164.50 | 2024 | Coolseal Generator |
| Acclarent, INC | $135.02 | 2020-2021 | |
| Photonicare INC | $103.56 | 2022 | |
| Genzyme Corporation | $91.70 | 2023 | |
| Olympus America INC. | $82.68 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $46.66 | 2024-2025 | Vistaseal, Surgicel Nu-Knit, Dermabond |
| Regeneron Healthcare Solutions, INC. | $34.01 | 2023 | Dupixent |
| Lilly USA, LLC | $32.88 | 2025 | Zepbound, Mounjaro |
| Pacira Pharmaceuticals Incorporated | $23.33 | 2024 | Exparel |
| Hikma Pharmaceuticals USA | $20.48 | 2023 | Ryaltris |
| Kerecis Limited | $18.20 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manish Wani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.